Scisparc Ltd (SPRC)

$4.51 -0.40 (-8.15%)
Market Cap 2.41M
Revenue (ttm) 1.31M
Net Income (ttm) -6.28M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -479.39%
Debt to Equity Ratio 0.04
Volume 16,100
Avg Vol 29,343
Day's Range N/A - N/A
Shares Out 535,000.00
Stochastic %K 0%
Beta 0.88
Analysts Strong Buy
Price Target $20.00

Company Profile

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. It also sells hemp seed oil-based products and others. The company has an agreement with Procaps to develop and commercially manufac...

Industry: Biotechnology
Sector: Healthcare
Phone: 972 7 334 47180
Address:
Tower A, 2nd Floor 20 Raul Wallenberg Street, Tel Aviv, Israel
Mobiustripper
Mobiustripper Aug. 16 at 9:41 PM
$SPRC the week before the votes.. Should be fun
0 · Reply
ItTakesItAll
ItTakesItAll Aug. 14 at 1:06 PM
$SPRC quiet in here hmm? let's see for how long.
0 · Reply
Maze01
Maze01 Aug. 4 at 9:35 PM
$SPRC there are two Million shares the owner will Sell and bring on the market
0 · Reply
TwongStocks
TwongStocks Aug. 4 at 8:19 PM
One month post-RS recap. $SPRC 1:21 RS on Jul 21, closed $6.60 Low volume since the RS. Most days were below 60k. Highest volume was Jul 31 when it went over 255k. Hit its peak of $8.48 on Jul 23, a day after they announced they regained NASDAQ compliance. Since then it slowly went down. Today closed $5.99, down 9.24% from RS close.
0 · Reply
AnudderBrainlessMoron
AnudderBrainlessMoron Aug. 4 at 4:40 PM
$SPRC this turned into a triangle of muleshit
0 · Reply
ItTakesItAll
ItTakesItAll Aug. 4 at 12:00 PM
$SPRC Adding again 5.50-6.0s
0 · Reply
Jet1227
Jet1227 Aug. 3 at 4:48 AM
$SPRC are we gonna be millionaires soon?
1 · Reply
Bren10OD
Bren10OD Jul. 31 at 7:39 PM
$SPRC anyone have an opinion on why this dipped so hard? Was getting excited it was above 9.00
0 · Reply
OpenOutcrier
OpenOutcrier Jul. 31 at 11:30 AM
$SPRC (-8.8% pre) SciSparc Secures Critical SEC Approval for Electric Vehicle Merger with AutoMax Motors https://ooc.bz/l/72017
0 · Reply
Spacerobot
Spacerobot Jul. 31 at 10:29 AM
$SPRC These spikes are tempting, but the no vol is annoying.
0 · Reply
Latest News on SPRC
SciSparc-Clearmind Collaboration Leads to Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar

Aug 7, 2025, 7:32 AM EDT - 11 days ago

SciSparc-Clearmind Collaboration Leads to Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar

SciSparc Announces Updates Regarding Proposed Merger; Form F-4 Registration Statement Has Been Declared Effective by SEC

Jul 30, 2025, 4:34 PM EDT - 18 days ago

SciSparc Announces Updates Regarding Proposed Merger; Form F-4 Registration Statement Has Been Declared Effective by SEC

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease

Jul 30, 2025, 8:12 AM EDT - 19 days ago

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease

SciSparc Ltd. Regains Compliance with Nasdaq Minimum Bid Price Notification

Jul 22, 2025, 7:32 AM EDT - 27 days ago

SciSparc Ltd. Regains Compliance with Nasdaq Minimum Bid Price Notification

SciSparc Announces 1-for-21 Reverse Share Split

Jun 24, 2025, 5:03 PM EDT - 7 weeks ago

SciSparc Announces 1-for-21 Reverse Share Split

SciSparc Announces Publication of Japanese Patent Application

May 27, 2025, 7:32 AM EDT - 2 months ago

SciSparc Announces Publication of Japanese Patent Application

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

Apr 25, 2025, 7:59 AM EDT - 4 months ago

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

CMND

SciSparc Signs Definitive Agreement to Sell MitoCareX, Computational Drug Discovery Company Targeting Resistant Cancers

Mar 3, 2025, 8:25 AM EST - 6 months ago

SciSparc Signs Definitive Agreement to Sell MitoCareX, Computational Drug Discovery Company Targeting Resistant Cancers

SciSparc Extends $2 Million Loan to Support AutoMax's Growth Following AutoMax's Entry into Direct Import of JAC Electric Vehicles

Feb 27, 2025, 8:45 AM EST - 6 months ago

SciSparc Extends $2 Million Loan to Support AutoMax's Growth Following AutoMax's Entry into Direct Import of JAC Electric Vehicles

SciSparc Secures Favorable Settlement in Lawsuit It Filed, Receiving Cash Compensation and a Full Release from All Commitments, Royalties, and Allegations Asserted Against It on Claimed Core Technology

Feb 18, 2025, 7:17 AM EST - 6 months ago

SciSparc Secures Favorable Settlement in Lawsuit It Filed, Receiving Cash Compensation and a Full Release from All Commitments, Royalties, and Allegations Asserted Against It on Claimed Core Technology

SciSparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico

Feb 4, 2025, 9:00 AM EST - 6 months ago

SciSparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in Mexico

SciSparc Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement

Jan 15, 2025, 7:34 AM EST - 7 months ago

SciSparc Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement

SciSparc: AutoMax Enters the Direct Import Market with a $13 Million First Shipment of JAC Electric Vehicles

Jan 13, 2025, 8:41 AM EST - 7 months ago

SciSparc: AutoMax Enters the Direct Import Market with a $13 Million First Shipment of JAC Electric Vehicles

SciSparc: MitoCareX Bio Expands Research to Pancreatic Cancer Following Initial In-Vitro Positive Results

Jan 7, 2025, 7:25 AM EST - 7 months ago

SciSparc: MitoCareX Bio Expands Research to Pancreatic Cancer Following Initial In-Vitro Positive Results

Why Is Psychedelic-SciSparc Stock Trading Higher On Monday?

Jan 6, 2025, 11:04 AM EST - 8 months ago

Why Is Psychedelic-SciSparc Stock Trading Higher On Monday?

SciSparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

Jan 6, 2025, 7:50 AM EST - 8 months ago

SciSparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

SciSparc Announces Renewal of Approval by Israeli Medical Cannabis Agency for its Clinical Trial in Children with Autism Spectrum Disorder

Dec 31, 2024, 9:24 AM EST - 8 months ago

SciSparc Announces Renewal of Approval by Israeli Medical Cannabis Agency for its Clinical Trial in Children with Autism Spectrum Disorder

S&P 500 Edges Lower, SciSparc Shares Surge

Dec 26, 2024, 2:36 PM EST - 8 months ago

S&P 500 Edges Lower, SciSparc Shares Surge

SciSparc: AutoMax Announces $13 Million First Delivery of JAC Vehicles Following Regulatory Approval for Direct Importation

Dec 26, 2024, 6:46 AM EST - 8 months ago

SciSparc: AutoMax Announces $13 Million First Delivery of JAC Vehicles Following Regulatory Approval for Direct Importation

SciSparc Provides Updates on Status of Spin-off of its Advanced Clinical Stage Pharmaceutical Portfolio to a Publicly Traded Company

Dec 16, 2024, 7:40 AM EST - 8 months ago

SciSparc Provides Updates on Status of Spin-off of its Advanced Clinical Stage Pharmaceutical Portfolio to a Publicly Traded Company

SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome Treatment

Sep 30, 2024, 9:25 AM EDT - 11 months ago

SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome Treatment

SciSparc Signs Non-Binding Letter of Intent to Sell Stake in MitoCareX

Sep 26, 2024, 9:05 AM EDT - 11 months ago

SciSparc Signs Non-Binding Letter of Intent to Sell Stake in MitoCareX

SciSparc Receives FDA Approval to Initiate Phase IIb Clinical Trial for Tourette Syndrome Treatment

Sep 23, 2024, 8:17 AM EDT - 11 months ago

SciSparc Receives FDA Approval to Initiate Phase IIb Clinical Trial for Tourette Syndrome Treatment

SciSparc Takes Major Step Forward with IND Application submitted to the FDA for Phase IIb Clinical Trial for Tourette Syndrome Treatment

Sep 18, 2024, 4:09 PM EDT - 11 months ago

SciSparc Takes Major Step Forward with IND Application submitted to the FDA for Phase IIb Clinical Trial for Tourette Syndrome Treatment

SciSparc-Clearmind Medicine Collaboration Announces the Publication of an International Patent Application for Pioneering Ibogaine Combination Therapy

Sep 16, 2024, 4:06 PM EDT - 11 months ago

SciSparc-Clearmind Medicine Collaboration Announces the Publication of an International Patent Application for Pioneering Ibogaine Combination Therapy

SciSparc Advances $1.85 million Loan to AutoMax, Following AutoMax's Direct Import Agreement with Major Chinese Vehicle Manufacturer

Sep 11, 2024, 7:40 AM EDT - 1 year ago

SciSparc Advances $1.85 million Loan to AutoMax, Following AutoMax's Direct Import Agreement with Major Chinese Vehicle Manufacturer

SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination Treatment

Sep 6, 2024, 7:55 AM EDT - 1 year ago

SciSparc-Clearmind Medicine Collaboration Leads to Publication of International Patent Application for Innovative MDMA-Based Combination Treatment

SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based Combination

Aug 29, 2024, 4:25 PM EDT - 1 year ago

SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based Combination

SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to $6 Million

Aug 28, 2024, 8:55 AM EDT - 1 year ago

SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to $6 Million

SciSparc Submitted IND Application to the FDA for SCI-110 Phase IIb Clinical Trial for Patients with Tourette Syndrome

Aug 23, 2024, 4:09 PM EDT - 1 year ago

SciSparc Submitted IND Application to the FDA for SCI-110 Phase IIb Clinical Trial for Patients with Tourette Syndrome

SciSparc: MitoCareX Appointed Professor Nir Peled, Seasoned Oncologist, to its Scientific Advisory Board

Aug 22, 2024, 8:12 AM EDT - 1 year ago

SciSparc: MitoCareX Appointed Professor Nir Peled, Seasoned Oncologist, to its Scientific Advisory Board

SciSparc Announces Enrollment of the First Five Patients in the Clinical Trial of its Innovative SCI-210 Treatment

Aug 19, 2024, 4:11 PM EDT - 1 year ago

SciSparc Announces Enrollment of the First Five Patients in the Clinical Trial of its Innovative SCI-210 Treatment

Israeli Penny Stock Biotech SciSparc Outlicenses Its Cannabinoid Pain Therapy

Aug 19, 2024, 7:51 AM EDT - 1 year ago

Israeli Penny Stock Biotech SciSparc Outlicenses Its Cannabinoid Pain Therapy

SciSparc Finalizes Exclusive Global Out-Licensing Agreement for its Pain Therapy Valued at $3 million

Aug 16, 2024, 4:30 PM EDT - 1 year ago

SciSparc Finalizes Exclusive Global Out-Licensing Agreement for its Pain Therapy Valued at $3 million

SciSparc Updates Regarding the Status of the AutoMax Merger

Aug 14, 2024, 4:53 PM EDT - 1 year ago

SciSparc Updates Regarding the Status of the AutoMax Merger

SciSparc's Collaboration with Clearmind Medicine Continues to Bear Fruit With New Scientific Article Showing MEAI Potential as a Novel Weight Loss Drug

Aug 6, 2024, 8:57 AM EDT - 1 year ago

SciSparc's Collaboration with Clearmind Medicine Continues to Bear Fruit With New Scientific Article Showing MEAI Potential as a Novel Weight Loss Drug

SciSparc: MitoCareX Confirms Potential Significant Role of its Drug Target in Non-Small Cell Lung Cancer

Jul 22, 2024, 8:20 AM EDT - 1 year ago

SciSparc: MitoCareX Confirms Potential Significant Role of its Drug Target in Non-Small Cell Lung Cancer

SciSparc Signs Non-Binding Letter of Intent for Exclusive Global Out-Licensing of Pain Treatment for Approximately $6 million

Jul 17, 2024, 7:07 AM EDT - 1 year ago

SciSparc Signs Non-Binding Letter of Intent for Exclusive Global Out-Licensing of Pain Treatment for Approximately $6 million

SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification

Jul 16, 2024, 11:55 AM EDT - 1 year ago

SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification

SciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight Loss

Jul 16, 2024, 6:03 AM EDT - 1 year ago

SciSparc Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight Loss

SciSparc Signs Non-Binding Letter of Intent for Spin Off of Advanced Clinical Stage Pharmaceutical Portfolio to Publicly Traded Company

Jul 8, 2024, 8:30 AM EDT - 1 year ago

SciSparc Signs Non-Binding Letter of Intent for Spin Off of Advanced Clinical Stage Pharmaceutical Portfolio to Publicly Traded Company

SciSparc Secures Strategic Advantage with Grant of European Patent

May 31, 2024, 7:17 AM EDT - 1 year ago

SciSparc Secures Strategic Advantage with Grant of European Patent

Action Alliance Research: Family, Friends Need More Resources and Support to Help Loved Ones Who Are Struggling with Their Mental Health

May 21, 2024, 9:26 AM EDT - 1 year ago

Action Alliance Research: Family, Friends Need More Resources and Support to Help Loved Ones Who Are Struggling with Their Mental Health

SciSparc to Acquire AutoMax

Apr 11, 2024, 8:15 AM EDT - 1 year ago

SciSparc to Acquire AutoMax

SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression

Mar 27, 2024, 8:55 AM EDT - 1 year ago

SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression

SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research

Mar 21, 2024, 8:58 AM EDT - 1 year ago

SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research

SciSparc Granted Another Patent, Strengthening its Core Technology in Canada

Mar 18, 2024, 7:29 AM EDT - 1 year ago

SciSparc Granted Another Patent, Strengthening its Core Technology in Canada

SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial

Mar 14, 2024, 8:49 AM EDT - 1 year ago

SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial

SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure

Mar 12, 2024, 8:14 AM EDT - 1 year ago

SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure

SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder

Mar 8, 2024, 7:11 AM EST - 1 year ago

SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder

Mobiustripper
Mobiustripper Aug. 16 at 9:41 PM
$SPRC the week before the votes.. Should be fun
0 · Reply
ItTakesItAll
ItTakesItAll Aug. 14 at 1:06 PM
$SPRC quiet in here hmm? let's see for how long.
0 · Reply
Maze01
Maze01 Aug. 4 at 9:35 PM
$SPRC there are two Million shares the owner will Sell and bring on the market
0 · Reply
TwongStocks
TwongStocks Aug. 4 at 8:19 PM
One month post-RS recap. $SPRC 1:21 RS on Jul 21, closed $6.60 Low volume since the RS. Most days were below 60k. Highest volume was Jul 31 when it went over 255k. Hit its peak of $8.48 on Jul 23, a day after they announced they regained NASDAQ compliance. Since then it slowly went down. Today closed $5.99, down 9.24% from RS close.
0 · Reply
AnudderBrainlessMoron
AnudderBrainlessMoron Aug. 4 at 4:40 PM
$SPRC this turned into a triangle of muleshit
0 · Reply
ItTakesItAll
ItTakesItAll Aug. 4 at 12:00 PM
$SPRC Adding again 5.50-6.0s
0 · Reply
Jet1227
Jet1227 Aug. 3 at 4:48 AM
$SPRC are we gonna be millionaires soon?
1 · Reply
Bren10OD
Bren10OD Jul. 31 at 7:39 PM
$SPRC anyone have an opinion on why this dipped so hard? Was getting excited it was above 9.00
0 · Reply
OpenOutcrier
OpenOutcrier Jul. 31 at 11:30 AM
$SPRC (-8.8% pre) SciSparc Secures Critical SEC Approval for Electric Vehicle Merger with AutoMax Motors https://ooc.bz/l/72017
0 · Reply
Spacerobot
Spacerobot Jul. 31 at 10:29 AM
$SPRC These spikes are tempting, but the no vol is annoying.
0 · Reply
Spacerobot
Spacerobot Jul. 31 at 10:28 AM
$SPRC Mergers are opaque and are cover to unload shares not on the books often.
0 · Reply
Love_To_Learn
Love_To_Learn Jul. 31 at 12:50 AM
$SPRC was working on u discretely today
0 · Reply
leon_dedrick
leon_dedrick Jul. 30 at 9:05 PM
$SPRC I dont have time for this slow ass shit........Im out. Yall can have them 800 dollars.
0 · Reply
leon_dedrick
leon_dedrick Jul. 30 at 8:55 PM
$SPRC It traded 240K shares all day so its an easy short target..... No interest from the market means shorts can push this as low as they want it......over time.
0 · Reply
leon_dedrick
leon_dedrick Jul. 30 at 8:48 PM
$SPRC Weird movement....
0 · Reply
slacktime
slacktime Jul. 30 at 8:44 PM
$SPRC send this tiny float! Merger news!
0 · Reply
shavitmi
shavitmi Jul. 30 at 8:41 PM
$SPRC https://finance.yahoo.com/news/scisparc-announces-updates-regarding-proposed-203400196.html $SBET
0 · Reply
leon_dedrick
leon_dedrick Jul. 30 at 8:39 PM
$SPRC The whole move played out in about 20 seconds
0 · Reply
shavitmi
shavitmi Jul. 30 at 8:38 PM
$SPRC tiny float (540k) merger news $IXHL
0 · Reply
JimBull
JimBull Jul. 30 at 8:36 PM
$SPRC low float with merger news:
0 · Reply
Meta4
Meta4 Jul. 30 at 5:35 PM
$SPRC This company has loaned Automax $6.25 million ... has sold its interest in Mitocare for $700,00 plus 20% equity in $NITO and holds approximately 70% of the shares of Miza which seems to have disappeared and $3 million equity in Polyrizon? Am I missing sanything? Market cap around $3 million?
0 · Reply
JSS777
JSS777 Jul. 30 at 2:59 PM
$SPRC this is truly a piece of shit
0 · Reply